Suppr超能文献

治疗后 HIV 感染者预后预测模型的系统评价和 Meta 分析研究方案。

Prognostic prediction models for treatment experienced people living with HIV: a protocol for systematic review and meta-analysis.

机构信息

School of Public Health, Fudan University, Shanghai, China.

Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.

出版信息

BMJ Open. 2024 Aug 24;14(8):e081129. doi: 10.1136/bmjopen-2023-081129.

Abstract

INTRODUCTION

Despite the favourable efficacy of antiretroviral therapy (ART), HIV/AIDS continues to impose significant disease burdens worldwide. This study aims to systematically review published prognostic prediction models for survival outcomes of treatment experienced people living with HIV (TE-PLHIV), to describe their characteristics, compare their performance and assess the risk of bias and real-world clinical utility.

METHODS AND ANALYSIS

Studies will be identified through a comprehensive search in PubMed, EMBASE, Scopus, the Cochrane Library, and OpenGrey databases. Two reviewers will independently conduct a selection of eligible studies, data extraction and critical appraisal. Included studies will be systematically summarised using appropriate tools designed for prognostic prediction modelling studies. Where applicable, evidence will be summarised with meta-analyses.

ETHICS AND DISSEMINATION

Ethical approval is not required because only available published data will be analysed. The results of this work will be published in a peer-reviewed journal.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO registration number CRD42023412118.

摘要

简介

尽管抗逆转录病毒疗法(ART)具有良好的疗效,但艾滋病毒/艾滋病仍在全球造成重大疾病负担。本研究旨在系统地综述已发表的用于预测治疗经验丰富的艾滋病毒感染者(TE-PLHIV)生存结局的预后预测模型,描述其特征,比较其性能,并评估偏倚风险和真实世界的临床实用性。

方法和分析

将通过在 PubMed、EMBASE、Scopus、Cochrane 图书馆和 OpenGrey 数据库中进行全面检索来识别研究。两名评审员将独立进行合格研究的选择、数据提取和关键评估。将使用专门为预后预测模型研究设计的适当工具对纳入的研究进行系统总结。在适用的情况下,将进行荟萃分析以总结证据。

伦理和传播

由于仅分析可用的已发表数据,因此不需要伦理批准。本研究的结果将发表在同行评议的期刊上。

系统评价注册

PROSPERO 注册号 CRD42023412118。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验